IRF4 and neoplasm: Finally, by intersecting copy number analysis of our tumour collection with genome‐wide CRISPR dependency data, we revealed a potential vulnerability driven by amplification of the transcription factor IRF4, a result with implications for our understanding of melanoma biology.